The long-term research goals of Dr. Giangrande’s laboratory are to develop RNA-based tools to modulate cellular pathways underlying pathological cell proliferation in the setting of cancer and cardiovascular disease. Her emerging interests include the development of diagnostic tools for imaging cancers and cardiovascular disease in vivo. In May 2013, she will receive the American Society of Gene and Cell Therapy’s Young Investigator Award at the ASGCT’s annual meeting.